Abstract:Germline mutations in the breast cancer susceptibility genes BRCA1 and BRCA2 have been linked to the development of breast cancer, ovarian cancer, and other malignancies. Recent studies suggest that the BRCA1 and BRCA2 gene products may function in the sensing and/or repair of DNA damage. To investigate this possibility, we determined the effects of various DNA-damaging agents and other cytotoxic agents on the mRNA levels of BRCA1 and BRCA2 in the MCF-7 and other human breast cancer cell lines. We found that several agents, including adriamycin (a DNA intercalator and inhibitor of topoisomerase II), camptothecin (a topoisomerase I inhibitor), and ultraviolet radiation induced significant decreases in BRCA1 and BRCA2 mRNA levels. Decreased levels of BRCA1 and BRCA2 mRNAs were observed within 6–12 h after treatment with adriamycin and persisted for at least 72 h. Adriamycin also induced decreases in BRCA1 protein levels; but these decreases required several days. U.V. radiation induced dose-dependent down-regulation of BRCA1 and BRCA2 mRNAs, with significant decreases in both mRNAs at doses as low as 2.5 J/m2, a dose that yielded very little cytotoxicity. Adriamycin-induced down-regulation of BRCA1 and BRCA2 mRNAs was first observed at doses that yielded relatively little cytotoxicity and little or no apoptotic DNA fragmentation. Adriamycin and U.V. radiation induced distinct dose- and time-dependent alterations in the cell cycle distribution; but these alterations did not correlate well with corresponding changes in BRCA1 and BRCA2 mRNA levels. However, the adriamycin-induced reduction in BRCA1 and BRCA2 mRNA levels was correlated with p53 functional status. MCF-7 cells transfected with a dominant negative mutant p53 (143 val→ala) required at least tenfold higher doses of adriamycin to down-regulate BRCA1 and BRCA2 mRNAs than did parental MCF-7 cells or control-transfected MCF-7 clones. These results suggest that BRCA1 and BRCA2 may play roles in the cellular response to DNA-damaging agents and that there may be a p53-sensitive component to the regulation of BRCA1 and BRCA2 mRNA expression.

Brca2 Suppresses Cell Proliferation Via Stabilizing Mage-D1

Brca1 Suppresses Epithelial-To-Mesenchymal Transition And Stem Cell Dedifferentiation During Mammary And Tumor Development

BRCA1 regulates gene expression for orderly mitotic progression.

Abstract P4-05-01: Genetic Analysis of the Role of Brca1 in Suppression of Basal-Like Breast Cancer

The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy

Regulation of BRCA1 and BRCA2 Expression in Human Breast Cancer Cells by DNA-damaging Agents.

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect via the PI3K/AKT signaling pathway

BRCA1 Represses DNA Replication Initiation Through Antagonizing Estrogen Signaling and Maintains Genome Stability in Parallel with WEE1-MCM2 Signaling During Pregnancy.

Abstract #4440: BRCA1 Modulates Malignant Cell Behavior, the Expression of Survivin and Chemosensitivity in Human Breast Cancer Cells

MAGE-D1 inhibits proliferation, migration and invasion of human breast cancer cells

BRCA1 Regulates Human Mammary Stem/progenitor Cell Fate

Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1.

Role of the Tumor Suppressor Gene Brca1 in Genetic Stability and Mammary Gland Tumor Formation.

BRCA1 inhibition of telomerase activity in cultured cells.

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

BRCA1: Cell Cycle Checkpoint, Genetic Instability, DNA Damage Response and Cancer Evolution

Loss of Function of BRCA1 Promotes EMT in Mammary Tumors Through Activation of TGFβR2 Signaling Pathway

BRCA1 As a Potential Human Prostate Tumor Suppressor: Modulation of Proliferation, Damage Responses and Expression of Cell Regulatory Proteins

The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Centrosome Amplification and A Defective G(2)-M Cell Cycle Checkpoint Induce Genetic Instability in Brca1 Exon 11 Isoform-Deficient Cells